<DOC>
	<DOCNO>NCT00212121</DOCNO>
	<brief_summary>hypothesis : 10 Gy additional boost tumor bed yield increase local control 10 year 88 % 93 % , still acceptable cosmesis .</brief_summary>
	<brief_title>Radiation Dose Intensity Study Breast Cancer Young Women</brief_title>
	<detailed_description>Title study : Radiation dose intensity study breast cancer young woman : randomize phase III trial additional dose tumor bed . Background aim study : Several study show breast conserve therapy ( BCT ) yield similar survival rate mastectomy . BCT consist lumpectomy followed whole breast radiotherapy ( WBRT ) . Three study show additional dose tumor bed , 50 Gy WBRT , reduce local recurrence rate ( LRR ) . The large 3 study recent EORTC trial , also show young age independent risk factor LR BCT . In patient &lt; 51 year age , LR rate reduce 50 % 66 Gy dose tumor bed , compare 50 Gy ( 5-year LRR 12 % vs 5.9 % , p &lt; 0.02 ) . However , LRR young woman still quite high ( &gt; 1 % per year ) . Therefore first aim study investigate whether additional boost dose tumorbed ( 26 Gy ) reduce LRR . Therefore , compare effect low boost dose ( 16 Gy ) effect high boost dose ( 26 Gy ) LRR , also cosmetic outcome . The second , important aim study investigate whether find genetic protein profile correlate LRR , lymph node metastasis , distant metastasis , survival , radiosensitivity , age . For purpose obtain frozen tumor material blood sample many patient possible . Population , study design , intervention : Patients young 51 year age , stage T1-2N01-2aM0 breast cancer , tumor locally excise acceptable cosmetic result , randomize 16 Gy boost dose tumorbed 26 Gy boost dose tumor bed , 50 Gy WBRT . Patients stratify base age , tumor size , lymph node metastasis , estrogen receptor status , interstitial external boost irradiation , institution . In principle frozen tumor sample blood sample store patient . Endpoints statistic : The primary endpoint LRR 10 year . The secondary endpoint cosmetic result , quantify use digitize color photograph . In addition , patient ask give opinion cosmetic result use standardized questionnaire . To find increase local control rate 88 % 93 % 10 year , power 80 % significance level 5 % , 580 patient include treatment arm . Side study : An extremely important aspect trial obtain fresh tumor material blood sample . These used determine genetic protein profile aim find subgroup base profile , may take less advantage additional radiation treatment .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Age 50 year younger . Histological diagnosis invasive mammary cancer include subtypes invasive adenocarcinoma . Tumor location extension image prior surgery use least mammography ultrasound . Unicentric tumor multifocal tumor remove use wide local excision ; microscopic radical resection ( focally involve margin allow , define : DCIS invasive carcinoma 3 few lowpower field ( use x 4 objective x 10 ocular lens , diameter 5 mm per lowpower microscopic field ) . Sentinel lymph node biopsy and/or axillary lymph node dissection perform . Breast cancer stage : pT12pN02a M0 . No treatment allow prior surgery ( neoadjuvant chemotherapy , neoadjuvant hormonal therapy , preoperative radiotherapy ) . In case adjuvant chemotherapy give , wide local excision perform &lt; 10 week start radiotherapy . In case adjuvant chemotherapy give immediately surgery , wide local excision perform &lt; 6 month start radiotherapy , chemotherapy complete &lt; 6 week start radiotherapy . In case hormonal treatment plan , give completion radiotherapy . No previous history synchronous malignant tumor breast , previous history malignant disease , except adequately treat carcinoma situ cervix basal cell carcinoma skin . ECOG performance scale 2 less . Exclusion criterion : Residual microcalcifications mammogram . All histological type malignancy invasive adenocarcinoma . In situ carcinoma breast , without invasive tumor . Concurrent pregnancy . Multicentric tumor , multifocal . tumor excise use multiple excision * Invasive breast cancer breast .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>microarrays</keyword>
</DOC>